{
  "id": "5c88593d75a4a5d21900000a",
  "type": "summary",
  "question": "What is COG112?",
  "ideal_answer": "COG112 is a  a modified apoE-mimetic peptide, that results from the fusion of COG133 to a protein transduction domain. COG112 has significantly enhanced anti-inflammatory bioactivities in vitro.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/16740622"
  ],
  "snippets": [
    {
      "text": "Most notably, fusion of COG133 to a protein transduction domain creates COG112, a modified apoE-mimetic peptide with significantly enhanced anti-inflammatory bioactivities in vitro, and improved therapeutic effects on EAE in vivo, which renders a nearly full remission from the disability. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16740622",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}